- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
Prostate-cancer screening - what the U.S. Preventive Services Task Force left out - Abstract
November 18, 2011
One man at a time - resolving the PSA controversy - Abstract
November 18, 2011
Defining and predicting indolent and low risk prostate cancer - Abstract
November 18, 2011
Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy - Abstract
November 18, 2011
Image-guided dose-escalated intensity-modulated radiation therapy for prostate cancer: Treating to doses beyond 78 Gy - Abstract
November 18, 2011
Robot-assisted versus open radical prostatectomy: An evidence-based comparison - Abstract
November 17, 2011
Relationship of obesity, androgen receptor genotypes and biochemical failure after radical prostatectomy - Abstract
November 17, 2011
PSA doubling time predicts for the development of distant metastases for patients who fail 3DCRT Or IMRT using the Phoenix definition - Abstract
November 17, 2011
Long-term projections of the harm-benefit trade-off in prostate cancer screening are more favorable than previous short-term estimates - Abstract
November 17, 2011
No detection of XMRV in blood samples and tissue sections from prostate cancer patients in Northern Europe - Abstract
November 16, 2011
Consolidating risk estimates for radiation-induced complications in individual patient: Late rectal toxicity - Abstract
November 16, 2011
Detection of prostate cancer with complexed PSA and complexed/total PSA ratio - is there any advantage? - Abstract
November 16, 2011
Effects of commercially available soy products on PSA in androgen-deprivation-naïve and castration-resistant prostate cancer - Abstract
November 16, 2011
Prostate brachytherapy and second primary cancer risk: A competitive risk analysis - Abstract
November 16, 2011